Literature DB >> 6434847

Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation.

J B Clark, D J Hayes, J A Morgan-Hughes, E Byrne.   

Abstract

Mitochondrial myopathies are a clinical condition characterized by muscle weakness and fatigue in which the primary defect is localized at the level of the mitochondria. Microscopic examination shows accumulations of mitochondria at the fibre periphery (ragged red fibres) and in some cases mitochondrial paracrystalline inclusions. The spectrum of different mitochondrial defects so far described is reviewed and data from cases investigated in this laboratory are described. The first case was a 17-year-old boy with a multisystem disorder whose muscle mitochondria showed low respiratory activity with all substrates, which doubled in the presence of uncoupler. Further investigation showed that the mitochondrial ATPase activity was only 6% of normal. The next cases were a mother and daughter who showed a typical lipid storage myopathy. The latter was treated successfully with oral carnitine but the myopathy persisted. Mitochondrial investigations indicated a low respiratory activity with NAD-linked substrates but normal activity with succinate and ascorbate + TMPD. A defect in the NADH-CoQ reductase section of the respiratory chain was pinpointed possibly at an iron-sulphur centre. The fourth and fifth cases were two sisters who exhibited no lipid storage myopathy but whose mitochondrial activity was low with NAD-linked substrates but normal with succinate. Again a defect in the NADH-CoQ reductase (complex I) of the respiratory chain was determined. They were also investigated using 31P-NMR. It was found after exercise that their muscle creatine phosphate levels took seven times longer to return to pre-exercise concentrations than control subjects. These results are discussed with respect to the synthesis of mitochondrial proteins and the influence that both the mitochondrial and nuclear DNA have on this process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434847     DOI: 10.1007/bf03047377

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  54 in total

1.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

2.  Hereditary mitochondrial myopathy with lactic acidemia, a De Toni-Fanconi-Debré syndrome, and a defective respiratory chain in voluntary striated muscles.

Authors:  J P Van Biervliet; L Bruinvis; D Ketting; P K De Bree; C Van der Heiden; S K Wadman
Journal:  Pediatr Res       Date:  1977-10       Impact factor: 3.756

3.  Import of proteins into mitochondria. Import and maturation of the mitochondrial intermembrane space enzymes cytochrome b2 and cytochrome c peroxidase in intact yeast cells.

Authors:  G A Reid; T Yonetani; G Schatz
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

4.  Import of proteins into mitochondria. Energy-dependent, two-step processing of the intermembrane space enzyme cytochrome b2 by isolated yeast mitochondria.

Authors:  G Daum; S M Gasser; G Schatz
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

5.  An approach to population and evolutionary genetic theory for genes in mitochondria and chloroplasts, and some results.

Authors:  C W Birky; T Maruyama; P Fuerst
Journal:  Genetics       Date:  1983-03       Impact factor: 4.562

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  Models of mitochondrial DNA transmission genetics and evolution in higher eucaryotes.

Authors:  R W Chapman; J C Stephens; R A Lansman; J C Avise
Journal:  Genet Res       Date:  1982-08       Impact factor: 1.588

8.  Partial deficiency of carnitine palmityltransferase: physiologic and biochemical consequences.

Authors:  R B Layzer; R J Havel; M B McIlroy
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

9.  Import of proteins into mitochondria. Yeast cells grown in the presence of carbonyl cyanide m-chlorophenylhydrazone accumulate massive amounts of some mitochondrial precursor polypeptides.

Authors:  G A Reid; G Schatz
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

10.  Pyruvate dehydrogenase deficiency restricted to brain.

Authors:  M Prick; F Gabreëls; W Renier; F Trijbels; H Jaspar; K Lamers; J Kok
Journal:  Neurology       Date:  1981-04       Impact factor: 9.910

View more
  10 in total

Review 1.  Mitochondrial myopathies.

Authors:  S DiMauro; E Bonilla; M Zeviani; S Servidei; D C DeVivo; E A Schon
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells.

Authors:  H R Scholte; H F Busch; I E Luyt-Houwen; M H Vaandrager-Verduin; H Przyrembel; W F Arts
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Histopathology of mitochondrial cytopathy and the Laurence-Moon-Biedl syndrome.

Authors:  P Runge; D Calver; J Marshall; D Taylor
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

Review 4.  Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.

Authors:  J A Morgan-Hughes; A H Schapira; J M Cooper; J B Clark
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

5.  Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Neal Flomenberg; Ruth C Birbe; Agnieszka K Witkiewicz; Anthony Howell; Stephanos Pavlides; Aristotelis Tsirigos; Adam Ertel; Richard G Pestell; Paolo Broda; Carlo Minetti; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

6.  Impaired mitochondrial beta-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria.

Authors:  N J Watmough; L A Bindoff; M A Birch-Machin; S Jackson; K Bartlett; C I Ragan; J Poulton; R M Gardiner; H S Sherratt; D M Turnbull
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Organic acids in urine of patients with congenital lactic acidoses: an aid to differential diagnosis.

Authors:  R A Chalmers
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.

Authors:  G Kurlemann; I Paetzke; H Möller; H Masur; G Schuierer; J Weglage; H G Koch
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

9.  Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.

Authors:  S Ogasahara; A G Engel; D Frens; D Mack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 10.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.